Northpointe Bancshares, Inc.

NYSE:NPB

Banks - Regional

Financial Services
$14.79 +0.11%

+$0.02 today

Market cap
$511.47M
Beta
0.11
P/E (TTM)
3.1
EPS (TTM)
$5.85
Dividend yield
0.56%
52W Low $12.95High $19.48

Volume 0.33M

Average 0.15M

NPB Inventory

Raw materials, work in progress, and finished goods held for sale.

Northpointe Bancshares, Inc.NYSE: NPB

Inventory · Q1 FY2026 · quarter ended Mar 2026

Inventory remains negative

Q1 FY2026 inventory was $0, compared with $0 a year earlier.

Context

  • Inventory amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Inventory increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
$0— since
Inventory past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Inventory history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Inventory vs competitors

How NPB compares with its peers on the latest reported figures

  • NPB's Mar 2026 inventory of $0 is the 3rd highest of the 7 companies compared; the peer median is $0.
  • Inventory amounts to 0.0% of total assets for NPB, versus a peer median of 0.0%.
NPB Competitors Peer median
Inventory for NPB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ZLABZai Lab LimitedJun 2026$90.89M +47.3%+33.2%8.5%
LEGNLegend Biotech CorporationSep 2026$39.8M +36.4%+45.7%2.4%
NPBNorthpointe Bancshares, Inc.Mar 2026$0 ——0.0%
ERASErasca, Inc.Sep 2026$0 ——0.0%
CGEMCullinan Therapeutics, Inc.Mar 2026$0 ——0.0%
CCCCC4 Therapeutics, Inc.Mar 2026$0 ——0.0%
ALXOALX Oncology Holdings Inc.Mar 2026$0 ——0.0%
Peer median (excluding NPB) $0+41.8%+39.4%0.0%

Competitors are the stored peer set for NPB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents552.8M3.21B2.14B498.25M496.46M
Short-term Investments118.16M239.99M143.22M767.38M0
Net Receivables60.95M01.83M028.3M
Inventory4.27M028.96M00
Other Current Assets0162.92M1.1M15.84M(28.3M)
Total Current Assets750.18M3.63B2.34B1.29B496.46M
Property, Plant & Equipment (Net)24.87M123.96M82.91M27.72M27.57M
Goodwill25.51M162.57M000
Intangible Assets18.77M118.88M118.11M17.23M18.56M
Long-term Investments55.24M30.85M12.08M224.98M6.33B
Tax Assets00000
Other Non-current Assets4.18M10.91M63.2M9.96M153.84M
Total Non-current Assets128.56M447.18M276.3M262.67M6.53B
Total Assets878.74M4.07B2.61B1.55B7.02B
Account Payables00000
Short-term Debt018.96M29.97M0420M
Tax Payables00000
Deferred Revenue371.66K011.21M00
Other Current Liabilities022.23M72.91M773.69K4.45B
Total Current Liabilities97.9M758.14M411.81M61.71M4.87B
Long-term Debt0058.91M01.54B
Deferred Tax Liabilities00003.79M
Deferred Revenue (Non-current)37.49M0000
Other Non-current Liabilities15.2M373.52M400.99M52043.92M
Total Non-current Liabilities65.52M405.59M483M22.38M1.58B
Total Liabilities163.42M1.16B894.81M84.09M6.45B
Common Stock19.77K131.99K133K138.68K0
Retained Earnings(683.21M)(6.86B)(8.33B)(9.39B)364.37M
Accumulated OCI(29.26M)213.79M298.29M243.67M(199K)
Other Stockholders Equity(0)3860(406)0
Minority Interest00000
Total Equity715.33M2.91B1.72B1.47B569.04M
Total Debt17.64M74.98M133.87M28.33M1.54B
Net Debt(535.16M)(3.14B)(2.01B)(469.92M)1.04B

Northpointe Bancshares, Inc.

NYSE:NPB

Intrinsic Alpha fair value

Locked

Current Price

$14.79

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.